⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17754493 | 1.00 | — | — | |
| SCHEMBL19566535 | 0.86 | — | — | |
| SCHEMBL17754490 | 0.86 | — | — | |
| SCHEMBL17754512 | 0.86 | — | — | |
| SCHEMBL12173554 | 0.86 | — | — | |
| SCHEMBL21202667 | 0.86 | — | — | |
| SCHEMBL15964501 | 0.86 | — | — | |
| SCHEMBL21202665 | 0.86 | — | — | |
| SCHEMBL24742683 | 0.84 | — | — | |
| SCHEMBL17754508 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170319614-A1 | ANTISENSE-OLIGONUCLEOTIDES AS INHIBITORS OF TGF-R SIGNALING | Neurovision Pharma GmbH (DE) | 2017-11-09 | — | — | US | disclosed |
| US-20170319614-A1 | ANTISENSE-OLIGONUCLEOTIDES AS INHIBITORS OF TGF-R SIGNALING | Neurovision Pharma GmbH (DE) | 2017-11-09 | — | — | US | disclosed |
| US-20160138029-A1 | ANTISENSE-OLIGONUCLEOTIDES AS INHIBITORS OF TGF-R SIGNALING | Neurovision Pharma GmbH (DE) | 2016-05-19 | — | — | US | disclosed |
| US-20160138029-A1 | ANTISENSE-OLIGONUCLEOTIDES AS INHIBITORS OF TGF-R SIGNALING | Neurovision Pharma GmbH (DE) | 2016-05-19 | — | — | US | disclosed |